Global Transfusion Diagnostic Equipment Market Size By Type (Molecular HLA Typing Diagnose Equipment, HLA Serology Diagnose Equipment), By Application (Pre-Transfusion Diagnostic, Post Transfusion Dia...

The Global Transfusion Diagnostic Equipment Market was valued at USD 5.6 billion in 2023 and is projected to surpass USD 9.3 billion by 2031, registering a CAGR of 6.8% during the forecast period of 2023-2031. The growing demand for blood transfusions due to rising cases of chronic diseases, increasing surgical procedures, and accidents is fueling the market. The advancements in transfusion diagnostic equipment, such as automation, artificial intelligence-based testing, and enhanced sensitivity in detecting infections, are expected to drive market growth.

With the increasing prevalence of blood disorders, including hemophilia and leukemia, blood transfusions have become a critical component of healthcare. The adoption of automated transfusion testing systems and the implementation of stringent blood screening regulations further support market expansion.

Market Drivers

Growing Demand for Blood Transfusions

The increasing need for blood transfusions in surgeries, trauma cases, and chronic disease management is a significant driver of market growth. According to the WHO, millions of blood transfusions occur annually, creating a steady demand for transfusion diagnostic equipment.

Technological Advancements in Transfusion Diagnostics

The introduction of automated blood testing systems, next-generation sequencing (NGS) in transfusion medicine, and AI-based blood matching solutions is enhancing diagnostic accuracy, reducing human errors, and improving efficiency. These innovations are crucial in minimizing transfusion-related risks.

Stringent Regulatory Guidelines for Blood Safety

Governments and healthcare organizations globally are implementing strict blood safety regulations to prevent transfusion-transmissible infections (TTIs) such as HIV, hepatitis, and syphilis. Compliance with these regulations is driving hospitals and blood banks to invest in advanced transfusion diagnostic equipment.

Market Restraints

High Cost of Advanced Transfusion Diagnostic Systems

The cost of automated transfusion analyzers, PCR-based screening tools, and NGS-based diagnostic systems is high, making them inaccessible for smaller hospitals and clinics, particularly in developing countries.

Limited Availability of Skilled Professionals

Handling advanced transfusion diagnostic systems requires trained personnel. The shortage of skilled laboratory technicians in various regions could hinder market growth.

Market Opportunity

Rising Adoption of AI and Automation in Blood Screening

The integration of AI and machine learning in transfusion diagnostics is paving the way for real-time risk assessment, precision matching of donor blood, and automated screening of TTIs, improving efficiency and accuracy.

Increasing Investments in Blood Banks and Healthcare Infrastructure

Emerging markets in Asia-Pacific and Latin America are witnessing large-scale investments in healthcare infrastructure, boosting the adoption of modern transfusion diagnostic technologies.

Market by System Type Insights

Based on system type, the Automated Transfusion Diagnostic Equipment segment held the largest market share in 2023. The demand for automated blood testing analyzers, ELISA-based diagnostic kits, and molecular diagnostic tools is increasing due to their efficiency, reliability, and high throughput. The manual diagnostic equipment segment is still widely used in resource-limited settings but is expected to grow at a slower pace.

Market by End-use Insights

The hospitals & blood banks segment accounted for the largest market share in 2023, owing to the high volume of blood transfusions and stringent safety protocols in these settings. Diagnostic laboratories are another key end-user segment, driven by the growing trend of outsourcing blood testing to specialized diagnostic centers.

Market by Regional Insights

North America dominated the market in 2023 due to well-established healthcare infrastructure, high adoption of automated diagnostic tools, and strict regulatory frameworks for blood transfusion safety.

Asia-Pacific is expected to witness the highest growth rate, driven by increasing healthcare investments, rising demand for safe blood transfusion practices, and the expansion of blood banks in China, India, and Japan.

Europe holds a significant market share due to government-supported initiatives for safe blood transfusion practices and the presence of leading diagnostic equipment manufacturers.

Competitive Scenario

Key players in the Global Transfusion Diagnostic Equipment Market include:

Abbott Laboratories

Bio-Rad Laboratories

Grifols S.A.

F. Hoffmann-La Roche Ltd.

Ortho Clinical Diagnostics

Siemens Healthineers

Beckman Coulter Inc.

Immucor Inc.

These companies are investing in product innovations, strategic partnerships, and acquisitions to expand their market presence.

Key Market Developments

In 2023, Abbott launched an AI-powered transfusion diagnostic system that enhances donor-recipient matching accuracy.

Grifols S.A. expanded its blood screening portfolio in 2024, introducing molecular diagnostic kits for faster detection of TTIs.

Ortho Clinical Diagnostics partnered with a leading blood bank in 2025 to deploy automated transfusion diagnostic systems across multiple centers.

Scope of Work – Global Transfusion Diagnostic Equipment Market

Report Metric Details

Market Size (2023) USD 5.6 billion

Projected Market Size (2031) USD 9.3 billion

CAGR (2023-2031) 6.8%

Key Segments by System Type Automated Transfusion Diagnostic Equipment, Manual Diagnostic Equipment

Key Segments by End-Use Hospitals & Blood Banks, Diagnostic Laboratories

Leading Region North America

Key Players Abbott Laboratories, Bio-Rad Laboratories, Grifols S.A., Siemens Healthineers, Ortho Clinical Diagnostics

FAQs

1. What is the current market size of the Global Transfusion Diagnostic Equipment Market?

The market was valued at USD 5.6 billion in 2023 and is expected to grow steadily during the forecast period.

2. What is the major growth driver of the Global Transfusion Diagnostic Equipment Market?

The primary driver is the rising demand for blood transfusions due to chronic diseases, surgeries, and trauma cases, along with advancements in automated diagnostic tools.

3. Which is the largest region during the forecast period in the Global Transfusion Diagnostic Equipment Market?

North America is expected to hold the largest market share due to advanced healthcare infrastructure and stringent blood screening regulations.

4. Which segment accounted for the largest market share in the Global Transfusion Diagnostic Equipment Market?

The Automated Transfusion Diagnostic Equipment segment accounted for the largest market share in 2023 due to high efficiency, reliability, and faster processing of blood samples.

5. Who are the key market players in the Global Transfusion Diagnostic Equipment Market?

Major players include Abbott Laboratories, Bio-Rad Laboratories, Grifols S.A., Ortho Clinical Diagnostics, Siemens Healthineers, and Beckman Coulter Inc..

This comprehensive report provides an in-depth analysis of the market trends, drivers, restraints, and opportunities shaping the future of the Global Transfusion Diagnostic Equipment Market.